Grifols, S.A.
OTC: GIFOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jose Ignacio Abia Buenache
- Employees
- 23,833
- Headquarters
- Barcelona, Spain
- IPO year
- 2013
- Market cap
- $8.7B
- Website
- https://www.grifols.com
Loading GIFOF…
Loading profile data…Frequently asked questions about GIFOF
What does Grifols, S.A. (GIFOF) do?
Grifols, S.A. is a Barcelona, Spain-based pharmaceutical company founded in 1940. The company primarily specializes in the acquisition, production, and distribution of therapeutic solutions, with a significant emphasis on products derived from human plasma. Its operations are divided into several key business units: The Bioscience division is de...
Where does GIFOF trade?
Grifols, S.A. (GIFOF) trades on the Other OTC.
What sector is GIFOF in?
Grifols, S.A. (GIFOF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Grifols, S.A.?
Jose Ignacio Abia Buenache is the chief executive officer of Grifols, S.A. (GIFOF).
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Spain.
Does GIFOF pay a dividend?
Yes — Grifols, S.A. (GIFOF) paid a trailing twelve-month dividend of USD 0.18 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GIFOF go public?
Grifols, S.A. (GIFOF) completed its initial public offering in 2013.